Westfield, NJ, United States of America

Robert E Schwartz

This inventor holds 22 USPTO granted patents and 1 published patent application, primarily in Antifungal Agents. Top assignee: Merck + Co., Inc.. Active years: 1989-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert E Schwartz. Retrieved from https://idiyas.com/inventor/robert-e-schwartz-z98cpm9u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 151(Granted Patents)


Location History:

  • Westfield, NJ (US) (1989 - 1995)
  • Scotch Plains, NJ (US) (1994 - 2002)

Company Filing History:


Years Active: 1989-2002

Loading Chart...
Areas of Expertise:
Antifungal Compounds
Lipopeptide Derivatives
Antibiotic Agents
Cyclohexapeptide
Fermentation Products
Hormonema
Arthrinium Arundinis
Sordarin Compounds
Crystalline Cyclic Lipopeptides
Vasopressin Antagonists
Hapalindolinone
Tri-yne Carbonates
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert E. Schwartz

Introduction

Robert E. Schwartz, a distinguished inventor based in Westfield, NJ, has made significant strides in the field of antifungal solutions through his innovative patents. With a total of 22 patents to his name, Schwartz's work has made a considerable impact in agricultural biotechnology, particularly in combating plant diseases caused by fungi.

Latest Patents

Among Schwartz's latest patents are groundbreaking inventions related to controlling phytopathogenic fungi. His patents include the strains Rosellinia subiculata ATCC 74386 and fungus ATCC 74387, which are critical for producing sordarin compounds aimed at fungal control. The disclosed methods involve cultivating these strains in nutrient media rich in carbon and nitrogen sources, promoting the recovery of a sordarin compound. Additionally, Schwartz has introduced antifungal compositions that utilize these compounds, showcasing a novel compound derived from hormonema that exhibits significant antifungal activity.

Career Highlights

Schwartz's career is marked by his pivotal role at Merck & Company, Inc., where he has contributed to advancements in the pharmaceutical and agritech sectors. His expertise in developing antifungal agents has positioned him as a leading figure in the fight against agricultural diseases, ensuring healthier crops and more sustainable farming practices.

Collaborations

Throughout his career, Schwartz has collaborated with industry experts, including notable coworkers like Jerrold M. Liesch and Robert A. Giacobbe. These partnerships have not only fostered innovation but have also enhanced the efficacy and reach of the solutions developed within his team at Merck & Company, Inc.

Conclusion

With his extensive patent portfolio and collaborative efforts, Robert E. Schwartz continues to influence the landscape of agricultural technology. His innovative approaches to controlling fungal infections through specific strains and compounds reflect a commitment to enhancing crop health and food security. As he progresses in his career, the contributions of Schwartz promise to address pressing challenges in the agricultural sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…